Publications by authors named "Markus Schmutz"

Claim this Profile
T
Toxicity testing in the 21st century beyond environmental chemicals.
Costanza Rovida, Shoji Asakura, Mardas Daneshian, Hana Hofman-Huether, Marcel Leist, Markus Schmutz

ALTEX· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse.
Richard M O'Connor, Deepak R Thakker, Markus Schmutz, Herman van der Putten, Daniel Hoyer

Neuropharmacology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinazolinedione sulfonamides: a novel class of competitive AMPA receptor antagonists with oral activity.
Manuel Koller, Kurt Lingenhoehl, Markus Schmutz, Ivan-Toma Vranesic, Joerg Kallen

Bioorg Med Chem Lett· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models.
H Steve White, Michael R Franklin, Harvey J Kupferberg, Markus Schmutz, James P Stables

Epilepsia· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global down-regulation of gene expression in the brain using RNA interference, with emphasis on monoamine transporters and GPCRs: implications for target characterization in psychiatric and neurological disorders.
Daniel Hoyer, Deepak R Thakker, François Natt, Rainer Maier, Dieter Huesken, Markus Schmutz

J Recept Signal Transduct Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMPA receptor antagonists: potential therapeutic applications.
Henri Mattes, Kurt Lingenhoehl, Hans Kalkman, Yves Auberson, Johanne Renaud, Markus Schmutz

Recent Pat CNS Drug Discov· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice.
Martin Gassmann, Hamdy Shaban, Réjan Vigot, Gilles Sansig, Corinne Haller, Markus Schmutz

J Neurosci· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.
Klemens Kaupmann, John F Cryan, Petrine Wellendorph, Cedric Mombereau, Gilles Sansig, Markus Schmutz

Eur J Neurosci· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition.
Yves P Auberson, Hans Allgeier, Serge Bischoff, Kurt Lingenhoehl, Robert Moretti, Markus Schmutz

Bioorg Med Chem Lett· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis